Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chen Chen
Observed name:
Chen, Chen
Institution:
First Affiliated Hospital of Zhengzhou University
Observed institutions:
China Pharmaceutical University,
Zhengzhou University,
First Affiliated Hospital of Zhengzhou University,
State Key Laboratory of Natural Medicine,
University College London
ORCID:
0000-0002-0425-5110
Observed ORCID:
0000-0002-0425-5110
OpenAlex ID:
A5049940195
The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities
2025
·
Zehua Wang
, Chen Chen
, et al.
·
MedComm
·
18
Health‐related quality of life in stage III‐IV melanoma treated with targeted therapy or immunotherapy: A systematic review on the adequacy of reporting and clinical issues in phase III randomized controlled trials
2022
·
Chen Chen
, Zehua Wang
, et al.
·
Cancer Medicine
·
11
Targeting CircAURKA prevents colorectal cancer progression via enhancing CTNNB1 protein degradation
2024
·
Zhenqiang Sun
, Pengyuan Dang
, et al.
·
Oncogene
·
9
Discovery of piperine derivatives as inhibitors of human dihydroorotate dehydrogenase to induce ferroptosis in cancer cells
2024
·
Jian-Fei Zhang
, Li-Hong Hong
, et al.
·
Bioorganic Chemistry
·
7
Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram
2023
·
Siyuan Wang
, Chen Chen
, et al.
·
Journal of Cancer Research and Clinical Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
45
H-index:
4
I10-index:
2
Year
Topic
Type